skip to Main Content

New advance in the research of Congenital Muscular Dystrophy due to Collagen Deficiency VI (CMD COL6)

The Fundación Noelia has funded an innovative study led by researcher Virginia Arechavala-Gomeza, which takes a step forward in the diagnosis and development of treatments for Congenital Muscular Dystrophy due to Collagen Deficiency VI (CMD COL6). Researchers have created a…

2025.02.13

An update on potential adjuvant therapies in Collagen VI CMD: Alisporivir, Givinostat and Omigapil

In recent years, news have emerged from time to time that point to the potential benefit of some drugs for congenital muscular dystrophy patients. Although they do not hope to cure the disease, these drugs do seek to alleviate the…

2021.03.30
Back To Top